Skip to main content

Advertisement

SpringerLink
Log in

Dedifferentiated liposarcoma in the abdominal cavity: a case report

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Liposarcoma adherent to the mesentery is extremely rare and difficult to diagnose. A 70-year-old woman presented to the hospital with a right lower abdominal mass. After surgical resection, the patient was diagnosed with dedifferentiated liposarcoma of the transverse colon with a mesenteric origin, and chemotherapy was administered. Diagnosing dedifferentiated liposarcoma of the transverse mesocolon based on imaging findings alone is challenging. Surgical resection can aid diagnosis. Moreover, cancer-specific genetic testing was performed in this case because dedifferentiated liposarcoma is a disease for which novel therapeutic agents are expected to be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Asano N, Yoshida A, Mitani S, et al. Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma. Oncotarget. 2017;8:12941–52.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hirata M, Asano N, Katayama K, et al. Integrated exome and RNA sequencing of dedifferentiated liposarcoma. Nat Commun. 2019;10:5683.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lee ATJ, Thway K, Huang PH, et al. Clinical and molecular spectrum of liposarcoma. J Clin Oncol. 2018;36:151–9.

    Article  CAS  PubMed  Google Scholar 

  4. Somaiah N, Beird HC, Barbo A, et al. Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations. Oncotarget. 2018;9:19891–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tyler R, Wanigasooriya K, Taniere P, et al. A review of retroperitoneal liposarcoma genomics. Cancer Treat Rev. 2020;86: 102013.

    Article  CAS  PubMed  Google Scholar 

  6. Cha EJ. Dedifferentiated liposarcoma of the small bowel mesentery presenting as a submucosal mass. World J Gastrointest Oncol. 2011;3:116–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sachidananda S, Krishnan A, Ramesh R, et al. Primary multiple mesenteric liposarcoma of the transverse mesocolon. Ann Coloproctol. 2013;29:123–5.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Winn B, Gao J, Akbari H, et al. Dedifferentiated liposarcoma arising from the sigmoid mesocolon: a case report. World J Gastroenterol. 2007;13:4147–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nijhuis PH, Sars PR, Plaat BE, et al. Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol. 2000;7:535–43.

    Article  CAS  PubMed  Google Scholar 

  10. Creytens D. What’s new in adipocytic neoplasia? Virchows Arch. 2020;476:29–39.

    Article  PubMed  Google Scholar 

  11. Bill KL, Casadei L, Prudner BC, et al. Liposarcoma: molecular targets and therapeutic implications. Cell Mol Life Sci. 2016;73:3711–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lahat G, Anaya DA, Wang X, et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol. 2008;15:1585–93.

    Article  CAS  PubMed  Google Scholar 

  13. Ghadimi MP, Al-Zaid T, Madewell J, et al. Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis. Ann Surg Oncol. 2011;18:3762–70.

    Article  PubMed  Google Scholar 

  14. Nakamura K, Nakamura T, Matsubara T, et al. Comparison between MRI, pathology and immunohistochemistry of the dedifferentiated liposarcoma. Chubu Nihon Seikeigeka Saigaigeka Gakkai Zasshi (Cent Jpn J Orthop Traumat). 2017;60:689–90 (in Japanese).

    Google Scholar 

  15. Gahvari Z, Parkes A. Dedifferentiated liposarcoma: systemic therapy options. Curr Treat Options Oncol. 2020;21:15.

    Article  PubMed  Google Scholar 

  16. Grifasi C, Calogero A, Carlomagno N, et al. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report. World J Surg Oncol. 2013;11:305.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358–70 (discussion 70-1).

    Article  PubMed  PubMed Central  Google Scholar 

  18. Vos M, Boeve WC, van Ginhoven TM, et al. Impact of primary tumor location on outcome of liposarcoma patients, a retrospective cohort study. Eur J Surg Oncol. 2019;45:2437–42.

    Article  CAS  PubMed  Google Scholar 

  19. Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.

    Article  PubMed  Google Scholar 

  20. Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13:1045–54.

    Article  CAS  PubMed  Google Scholar 

  21. Kawai A, Yonemori K, Takahashi S, et al. Systemic therapy for soft tissue sarcoma: proposals for the optimal use of pazopanib, trabectedin, and eribulin. Adv Ther. 2017;34:1556–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Schöffski P, Chawla S, Maki RG, et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet. 2016;387:1629–37.

    Article  PubMed  Google Scholar 

  23. Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol. 2021;32:1348–65.

    Article  CAS  PubMed  Google Scholar 

  24. Sunami K, Ichikawa H, Kubo T, et al. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study. Cancer Sci. 2019;110:1480–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Akira Tsunoda and Dr. Yasutaka Tono from the Department of Medical Oncology, Mie University Hospital and Dr. Hiroto Yuasa from the Department of Pathology Mie University Hospital, for them kind support.

Author information

Authors and Affiliations

  1. Department of Family Medicine, Mie Prefectural Ichishi Hospital, Tsu, Japan

    Marina Kuroda

  2. Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, 2-174 Edobashi, Mie, Tsu, 514-8507, Japan

    Reiko Yamada, Takamitsu Tanaka, Misaki Nakamura, Yasuhiko Hamada & Hayato Nakagawa

  3. Department of Endoscopy, Mie University Graduate School of Medicine, Tsu, Japan

    Junya Tsuboi, Masaki Katsurahara, Kyosuke Tanaka & Noriyuki Horiki

Authors
  1. Marina Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reiko Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takamitsu Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junya Tsuboi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Misaki Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaki Katsurahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasuhiko Hamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kyosuke Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Noriyuki Horiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hayato Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reiko Yamada.

Ethics declarations

Conflict of interest

The authors have no potential conflict of interest to declare.

Consent for publication

Written informed consent was obtained for the publication of this report and any accompanying images.

Statements of human and animal rights

All procedures performed in this study involving human participant was in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patients in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuroda, M., Yamada, R., Tanaka, T. et al. Dedifferentiated liposarcoma in the abdominal cavity: a case report. Clin J Gastroenterol 15, 1094–1100 (2022). https://doi.org/10.1007/s12328-022-01703-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-022-01703-8

Keywords

Search

Navigation